两种微创旁路移植手术治疗多支冠状动脉病变效果的对比
发布时间：2019-05-27 11:39
【摘要】：目的:对比分析研究分期杂交技术(staged-hybrid coronary revascularization,Staged-HCR)与微创双侧胸廓内动脉(bilateral internal thoracic artery,BITA)全动脉旁路移植术治疗多支冠状动脉病变的安全性和有效性。方法:自2014年8月至2017年2月,70名患者接受微创冠状动脉旁路移植术治疗多支冠状动脉血管病变,随机分为两组,其中应用微创直视冠状动脉旁路移植技术(minimally invasive direct coronary artery bypass grafting,MIDCAB)行左侧胸廓内动脉至冠状动脉前降支搭桥、结合经皮冠状动脉介入技术(percutaneous coronary intervention,PCI)治疗非前降支血管病变的Staged-HCR组患者40名;应用微创BITA旁路移植术治疗患者30名。对比两组患者的术前资料、术中血液制品使用情况、机械通气时间、监护室停留时间、术后主要心脑血管不良事件以及术后冠状动脉造影结果,分析两种微创方法治疗冠状动脉多支血管病变的安全性和有效性。结果:两组患者术前资料差异无统计学意义,均按计划接受微创搭桥治疗。在术后机械辅助通气时间[Staged-HCR组(11.2±8.7)h,微创BITA组(18.3±9.1)h,P=0.013]、监护室停留时间[Staged-HCR组(26.29±4.05)h,微创BITA组(44.74±28.75)h,P=0.022]以及累计伤口引流量[Staged-HCR组(695.57±250.46)m L,微创BITA组(1103.26±547.44)m L,P=0.03]方面,Staged-HCR技术更有优势。术后冠状动脉造影显示两种方法均取得较高的移植血管通畅率,两组患者住院期间未发生术后主要心脑血管不良事件。结论:Staged-HCR技术是治疗冠状动脉多支病变的一种微创方法,在治疗存在右冠状动脉主干病变再血管化方面有优势;微创BITA全动脉化旁路移植手术具备更优异的远期通畅率,且适用于不能耐受PCI治疗后双联抗血小板治疗的患者,本研究表明两种方法均安全且有效。
[Abstract]:Objective: to compare the safety and efficacy of staging crossbreeding (staged-hybrid coronary revascularization,Staged-HCR) and minimally invasive bilateral internal thoracic artery (bilateral internal thoracic artery,BITA) bypass grafting in the treatment of multi-vessel coronary artery disease. Methods: from August 2014 to February 2017, 70 patients underwent minimally invasive coronary artery bypass grafting for multi-vessel coronary artery disease and were randomly divided into two groups. Minimally invasive direct coronary artery bypass grafting (minimally invasive direct coronary artery bypass grafting,MIDCAB) was performed between the left internal thoracic artery and the anterior descending coronary artery, combined with percutaneous coronary intervention (percutaneous coronary intervention,). PCI) 40 patients in Staged-HCR group who were treated with non-anterior descending artery disease. 30 patients were treated with minimally invasive BITA bypass grafting. The preoperative data, the use of blood products during operation, the time of mechanical ventilation, the residence time of monitor room, the main cardiovascular and cerebrovascular adverse events after operation and the results of coronary angiography were compared between the two groups. To analyze the safety and effectiveness of two minimally invasive methods in the treatment of coronary artery multi-vessel disease. Results: there was no significant difference in preoperative data between the two groups. All patients were treated with minimally invasive bypass according to the plan. The postoperative mechanical ventilation time [Staged-HCR group (11.2 卤8.7) h, minimally invasive BITA group (18.3 卤9.1) h, P 鈮，
本文编号：2486117
[Abstract]:Objective: to compare the safety and efficacy of staging crossbreeding (staged-hybrid coronary revascularization,Staged-HCR) and minimally invasive bilateral internal thoracic artery (bilateral internal thoracic artery,BITA) bypass grafting in the treatment of multi-vessel coronary artery disease. Methods: from August 2014 to February 2017, 70 patients underwent minimally invasive coronary artery bypass grafting for multi-vessel coronary artery disease and were randomly divided into two groups. Minimally invasive direct coronary artery bypass grafting (minimally invasive direct coronary artery bypass grafting,MIDCAB) was performed between the left internal thoracic artery and the anterior descending coronary artery, combined with percutaneous coronary intervention (percutaneous coronary intervention,). PCI) 40 patients in Staged-HCR group who were treated with non-anterior descending artery disease. 30 patients were treated with minimally invasive BITA bypass grafting. The preoperative data, the use of blood products during operation, the time of mechanical ventilation, the residence time of monitor room, the main cardiovascular and cerebrovascular adverse events after operation and the results of coronary angiography were compared between the two groups. To analyze the safety and effectiveness of two minimally invasive methods in the treatment of coronary artery multi-vessel disease. Results: there was no significant difference in preoperative data between the two groups. All patients were treated with minimally invasive bypass according to the plan. The postoperative mechanical ventilation time [Staged-HCR group (11.2 卤8.7) h, minimally invasive BITA group (18.3 卤9.1) h, P 鈮，
本文编号：2486117
本文链接：https://www.wllwen.com/yixuelunwen/waikelunwen/2486117.html
最近更新
教材专著
